Funding Biopharma Innovation 2024

Funding Biopharma Innovation 2024

All event, early-bird and discount information you need to know for the Funding Biopharma Innovation 2024 conference.

Significant medical advances, such as mRNA vaccines and cell and gene therapies, have demonstrated the effectiveness and worth of funding biopharmaceutical innovation. Over the past two years, it has been more difficult to secure capital for new product development due to a combination of persistent cost pressures, competition for skilled personnel, and stringent regulations. Decision-makers are closely examining capital allocation, looking for ways to increase returns, whether to reallocate expenditure, and how to revamp partnership and business structures.


The Financial Times is bringing investors and innovators together to talk about partnership and finance options that can speed up clinical development and drug discovery in collaboration with Syneos Health. Come discuss the newest approaches to investing in clinical advances and learn how to de-risk investments in innovative pharmaceutical and biotech goods with us in person in Boston, USA, or virtually.  


March 12, 2024


08:00 AM to 11:00 AM


Boston, USA

Discount information for Funding Biopharma Innovation 2024 available below!


Financial Times Live



Funding Biopharma Innovation 2024

Event Agenda

Funding Biopharma Innovation 2024 conference covers a broad range of topics. The themes outlined below will serve as an indication what to expect during the conference. A more detailed agenda is available on the event website:



Event is for free

Discount Information

Below you will find all important details about early-bird tickets and discount vouchers you can use for this event.

Location Details: Funding Biopharma Innovation 2024

The Charles Hotel

1 Bennett St, Cambridge

MA 02138, USA

Subscribe to our Newsletter